RetailMeNot Inc (NASDAQ:SALE) SVP Jagjit Bath sold 2,500 shares of the stock on the open market in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $29.75, for a total transaction of $74,375.00. Following the completion of the sale, the senior vice president now directly owns 30,000 shares in the company, valued at approximately $892,500. RetailMeNot Inc (NASDAQ:SALE) stock performance was -5.39% in last session and finished the day at $23.87. Traded volume was 6,148,659 shares in the last session and the average volume of the stock remained 1.33 million shares. RetailMeNot Inc (NASDAQ:SALE) insider ownership is 3.40%.

Cheniere Energy, Inc. (NYSEMKT:LNG), will start exporting LNG in the first quarter of 2016, Jean Abiteboul, president of Cheniere Supply & Marketing Inc., said on May 19 in Amsterdam. The Houston-based company’s Sabine Pass terminal is the first to win full approval for U.S. exports from the Federal Energy Regulatory Commission since ConocoPhillips’s Alaskan Kenai plant in 1967. There were 14 more U.S. export terminals proposed to FERC as of May 21. Cheniere Energy, Inc. (NYSEMKT:LNG) dropped -1.54% to $58.15 yesterday on volume of 1,557,896 shares. The intra-day range of the stock was $57.85 – 58.99. Cheniere Energy, Inc. (NYSEMKT:LNG) has a market capitalization of $13.83 billion.

Sputnik will be positioned as a major competitor to Yandex, which is one the leading technology companies in Russia. They will also go against American Internet search and advertising giant Google. Yandex NV (NASDAQ:YNDX) has a 62 percent search market share in Russia, followed by Google Russia with 27.6 percent and Mail.Ru with 7.7 percent, according to LiveInternet. Yandex NV (NASDAQ:YNDX)’s stock on May 23, 2014 reported a increase of 0.34% to the closing price of $32.21. Its fifty two weeks range is $21.70 – 45.42. The total market capitalization recorded $10.35 billion. The overall volume in the last trading session was 6,043,155 shares. In its share capital, Yandex NV (NASDAQ:YNDX) has 321.40 million outstanding shares.

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Friday announced that its shareholders had approved 1-for-4 reverse stock split of Inovio common stock. INO shares sank more than 5% in morning trading. Inovio said that the effective date of the reverse stock split would be disclosed at a future date after Inovio complies with “standard NYSE administrative processes.” In a statement, Inovio President and CEO Dr. J. Joseph Kim said: “Our stockholders approved a reverse split to have our price and share structure reflect our leadership position in immunotherapies and expand our potential investor audience.” On Friday, shares of Inovio Pharmaceuticals Inc (NYSEMKT:INO) dropped -9.09% to close the day at $2.00. Company return on investment (ROI) is -37.10% and its monthly performance is recorded as -23.08%. Inovio Pharmaceuticals Inc (NYSEMKT:INO) quarterly revenue growth is -46.24%.